Tag Archives: ACA

CEOs Sound Out on Health Reform: Stop Swinging from the Fence

At last week’s  4th annual Prix Galien Forum hosted by the Alexandria Center in New York, industry leaders gathered to discuss trends and developments that shape the intersection between science and policy.  The centerpiece of the day was a panel on  US health reform – focused on rollout of the  Affordable Care Act — featuring […]
Posted in Events, leadership, People, R&D, Regulatory | Also tagged , , , , , , , , , , , | Leave a comment

Forbes Health Summit: Industry Leaders Ponder the New World of Consumer-Driven Care

In health care, it is the lowly consumer who is now calling the shots, driving product and process innovation in areas ranging from electronic medical records [EMR] to retail health clinics. This was the main theme among discussants at the Forbes magazine Healthcare Summit held here in New York on October 10.  The central question:  […]
Posted in leadership, Meetings, patient education, R&D, Strategy | Also tagged , , , , , , , , , , | Leave a comment

National Chains Carefully Circle Obamacare

by Tom Norton While US Pharma anxiously watches the initial roll out of Obamacare, there are those entities closely associated with the innovator Rx business that have a very different view on what Obamacare means to their concerns.  These firms are carefully circling the new law, thoughtfully observing its implementation, and, generally, viewing its startup […]
Posted in Guest Blog, healthcare, leadership, Legal, Market Access, Regulatory | Also tagged , , , , , , , , , | Leave a comment

Battle Escalates over 340B Drug Pricing Program

What was once an obscure federal policy for providing low-cost drugs to safety-net hospitals has grown into a program that requires extensive discounting to one-third of the nation’s hospitals and health clinics. Pharma companies are pushing back, heightening tensions between “covered entities” that qualify for greatly reduced prices on medicines under 340B — and manufacturers […]
Posted in healthcare, pricing, Regulatory, Sales, Strategy | Also tagged , , , , , , , , , , , , , | Leave a comment

Your 2014 Medicaid Sales & Marketing Plans

by Tom Norton If you are an Rx regional sales director or a product marketing manager, I have a somewhat provocative question for you:  How exactly are you planning your 2014 Medicaid strategy?
Posted in Advertising, Guest Blog, healthcare, Legal, Market Access, Marketing, pricing, Regulatory, Sales, Strategy | Also tagged , , , , , , , , , | Leave a comment
  • Categories

  • Meta